EIF4E1B
Eukaryotic translation initiation factor 4E type 1B
Also known as: FLJ36951, I4E1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NMX2
- Gene
- EIF4E1B
- Ensembl
- ENSG00000175766
- Chromosome
- 5
- Canonical length
- 242 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable RNA 7-methylguanosine cap binding activity and translation initiation factor activity. Predicted to be involved in translational initiation. Predicted to be located in cytoplasm. Predicted to be part of eukaryotic translation initiation factor 4F complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
242 residues, UniProt reviewed canonical sequence.
>A6NMX2|EIF4E1B
1 MLAVEVSEAE GGIREWEEEE KEEEAAERTP TGEKSPNSPR TLLSLRGKAR TGGPMEVKLE
61 LHPLQNRWAL WFFKNDRSRA WQDNLHLVTK VDTVEDFWAL YSHIQLASKL SSGCDYALFK
121 DGIQPMWEDS RNKRGGRWLV SLAKQQRHIE LDRLWLETLL CLIGESFEEH SREVCGAVVN
181 IRTKGDKIAV WTREAENQAG VLHVGRVYKE RLGLSPKTII GYQAHADTAT KSNSLAKNKF
241 VVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF4E1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 4.4 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 4.4 nTPM
- retina: 2.5 nTPM
- cerebellum: 2 nTPM
- amygdala: 1.7 nTPM
- hypothalamus: 1.1 nTPM
- epididymis: 1 nTPM
Single-cell type
- oocytes: 92 nCPM
- cone photoreceptor cells: 48 nCPM
- rod photoreceptor cells: 40 nCPM
- retinal ganglion cells: 27 nCPM
- retinal bipolar cells: 26 nCPM
- retinal amacrine cells: 24 nCPM
Immune cell
- basophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 7.1 nTPM
- white matter: 4.6 nTPM
- cerebellum: 3.7 nTPM
- amygdala: 2.9 nTPM
- pons: 2.9 nTPM
- basal ganglia: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF4E1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF4E1B as an antibody target. Whether an autoantibody or antibody against EIF4E1B could matter depends on whether native EIF4E1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF4E1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF4E1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...